GL1X · GenesisL1 explorer

MolNFT v1 · #48380 · protein

The structures of apo- and inhibitor bound human dihydroorotate dehydrogenase reveal conformational flexibility within the inhibitor binding site

2PRH · Dihydroorotate dehydrogenase, mitochondrial: “The structures of apo- and inhibitor bound human dihydroorotate dehydrogenase reveal conformational…”. X-ray diffraction, 4 ligands (FMN, ORO, 238), 4 pockets (best druggability 0.83).…

PDB
2PRH
Type
protein
Length
358 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Dihydroorotate dehydrogenase, mitochondrial
EC
1.3.99.11
UniProt
Q02127
Ligands
FMN, ORO, 238, DDQ
Pockets
4 · best druggability 0.83

Structure

x-ray diffraction · 1 distinct chain · 45% helix, 16% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ADihydroorotate dehydrogenase, mitochondrial (EC 1.3.99.11)protein35845% helix, 16% strandQ02127

Ligands and binding sites

  • FMN · Flavin mononucleotide · ligand · chains A
  • ORO · Orotic acid · ligand · chains A
  • 238 · 6-chloro-2-(2'-fluorobiphenyl-4-yl)-3-methylquinoline-4-carboxylic acid · ligand · chains A
  • DDQ · Decylamine-N,N-dimethyl-N-oxide · ligand · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

4 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
15870.830.8879FMN, ORO, 238, DDQ
21180.470.7919empty
3540.410.8217empty
4830.400.7818empty

Compared structures

  • 2PRH · The structures of apo- and inhibitor bound human dihydroorotate dehydrogenase reveal… · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.